Literature DB >> 17606314

Kinetic versus allosteric mechanisms to explain insurmountable antagonism and delayed ligand dissociation.

Georges Vauquelin1, Anna Szczuka.   

Abstract

The present review addresses the theories which have been advanced to explain experimental observations dealing with insurmountable antagonism and accelerated radioligand dissociation in the presence of an excess unlabelled ligand. We came to the perception that, for each of these phenomena, the theories can be placed into two distinctive categories. The "kinetic" interpretations attribute these phenomena to, respectively, the ability of antagonists to form long-lasting complexes with their cognate receptor and the ability of dissociated ligands to bind again to the same or neighbouring receptors rather than to diffuse away from the cell surface. On the other hand, these observations can also be explained by negative allosteric interactions among topographically distinct ligand binding sites at the same receptor or di/multimeric receptor complex.

Mesh:

Substances:

Year:  2007        PMID: 17606314     DOI: 10.1016/j.neuint.2007.05.005

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  7 in total

Review 1.  Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action.

Authors:  Georges Vauquelin; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

2.  Estimation of the dissociation rate of unlabelled ligand-receptor complexes by a 'two-step' competition binding approach.

Authors:  A Packeu; M Wennerberg; A Balendran; G Vauquelin
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 3.  Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism.

Authors:  Georges Vauquelin; Sophie Bostoen; Patrick Vanderheyden; Philip Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-14       Impact factor: 3.000

4.  Picomolar Affinity Antagonist and Sustained Signaling Agonist Peptide Ligands for the Adrenomedullin and Calcitonin Gene-Related Peptide Receptors.

Authors:  Jason M Booe; Margaret L Warner; Augen A Pioszak
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-24

5.  Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists.

Authors:  Vernon Seow; Junxian Lim; Adam J Cotterell; Mei-Kwan Yau; Weijun Xu; Rink-Jan Lohman; W Mei Kok; Martin J Stoermer; Matthew J Sweet; Robert C Reid; Jacky Y Suen; David P Fairlie
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

Review 6.  Ligands, their receptors and ... plasma membranes.

Authors:  G Vauquelin; A Packeu
Journal:  Mol Cell Endocrinol       Date:  2009-07-30       Impact factor: 4.102

7.  Synthesis and Pharmacological Evaluation of Triazolopyrimidinone Derivatives as Noncompetitive, Intracellular Antagonists for CC Chemokine Receptors 2 and 5.

Authors:  Natalia V Ortiz Zacarías; Jacobus P D van Veldhoven; Lisa S den Hollander; Burak Dogan; Joseph Openy; Ya-Yun Hsiao; Eelke B Lenselink; Laura H Heitman; Adriaan P IJzerman
Journal:  J Med Chem       Date:  2019-12-13       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.